Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery

Main Inclusion Criteria: * Male or female patient ≥ 18 years old * Subject have been informed and understand the nature and extent of the study, agree to its provisions and have provided written approved informed consent * Patient undergoing elective primary or redo open liver resection for hepatic colorectal metastases with a curative intent * Subject, who, in the opinion of the Clinical Investigator, is able to understand this clinical study, cooperate with the study procedures and is willing to return for the required post-treatment follow-up. Main Exclusion Criteria: * Known allergy or hypersensitivity to any component of the investigational treatment PuraStat® * Pregnant or interested in becoming pregnant during the duration of the study, or breast feeding * Concurrent participation in another clinical study with a medical device or medicinal product with interfering endpoints